TCL Archive Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991 November 9, 1990
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004